Sign In to Follow Application
View All Documents & Correspondence

Cosmetic Cream Cleanser

Abstract: N/A

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
06 November 2003
Publication Number
0
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application
Patent Number
Legal Status
Grant Date
2007-03-30
Renewal Date

Applicants

HINDUSTAN UNILEVER LIMITED
165 / 166, BACKBAY RECLAMATION, MUMBAI - 400 020, MAHARASHTRA, INDIA

Inventors

1. CROTTY, BRIAN ANDREW (AMERICAN)
UNILEVER HOME & PERSONAL CARE USA, 40 MERRITT BOULEVARD, TRUMBULL, CONNECTICUT 06611, USA

Specification

FORM -2
THE PATENTS ACT, 1970 (39 of 1970)
COMPLETE SPECIFICATION
(See Section 10)
COSMETIC CREAM CLEANSER
HINDUSTAN LEVER LIMITED, a company incorporated under the Indian Companies Act, 1913 and having its registered office at Hindustan Lever House, 165/166, Backbay Reclamation, Mumbai -400 020, Maharashtra, India
The following specification particularly describes the nature of the invention and the manner in which it is to be performed.

The invention concerns a cosmetic cream for cleansing skin and having excellent skinfeel properties.
Cream type cosmetic cleansers are difficult to formulate. The term "cream" requires both opacity and a certain thickness. Consumers associate the attributes of opacity and thickness with creamy products. Chemicals imparting these properties can interfere with lathering, phase stability on storage and skinfeel.
U.S. Patent 5,336,497 (Guerrero et al.) discloses cosmetic compositions functioning to remove soil from body surfaces. A combination of silicone copolyol sulfosuccinate and an amphoteric surfactant are employed to achieve a cleaning result.
U.S. Patent 5,236,710 (Guerrero et al.) is a related disclosure reporting on a combination of an anionic sulfosuccinate and an emulsifying polyacrylate. More particularly the patent refers to a silicone copolyol
sulfosuccinate and an acrylate/C10-C3o alkyl acrylate
crosspolymer.
U.S. Patent 6,113,892 (Newell et al.) discloses compositions delivering both a cleansing action and conditioning. Products disclosed include components which must be selected from a high foaming anionic surfactant, a polymeric cationic conditioning agent, a silicone copolyol sulfosuccinate, an emollient and water.

WO 02/092051

PCT/EP02/04955

Although there have been some significant advances in this art, improvements are still necessary to achieve creamy products with thickness and the proper aesthetics.
Accordingly, it is an advantage of the present invention to 5 provide a cosmetic cream cleanser which delivers a dense luxurious foam.
Another advantage of the present invention is to provide a cosmetic cream cleanser which is opaque and thick with nevertheless good lather characteristics.
10 These and other advantages of the present will become more readily apparent from consideration of the summary and detailed description which follows.
A cosmetic cream cleanser composition is provided which includes:
15 (i) from 0.1 to 20% of a silicate;
(ii) from 0.001 to 2% of a crosslinked
carboxyvinyl polymer other than a long
chain C10-C30 alkyl acrylate or
methacrylate containing polymer;
20 (iii) from 0.01 to 40% of a silicone copolyol
sulfosuccinate; and
(iv) a cosmetically acceptable carrier;
wherein the composition has a viscosity ranging from 20,000 to 500,000 cp.


WO 02/092051

PCT/EP02/04955
Now it has been discovered that a combination of a silicate, a crosslinked carboxyvinyl polymer and a silicone copolyol sulfosuccinate results in a cream cleansing composition with highly desirable characteristics. These include excellent 5 lather, good storage stability and a rich skinfeel.
A first element of the present invention is that of a silicate. Illustrative of this category are aluminum magnesium silicate, magnesium silicate, aluminum silicate, chemically modified magnesium aluminum silicate, smectite
10 clay, bentonites, hectorites, pyrogenic colloidal silica,
organically modified montmorillonite clay, hydrated aluminum silicate, fumed silica, barium silicate, calcium silicate, alumina, zeolite and combinations thereof. Particularly preferred is aluminum magnesium silicate available
15 commercially under the trademarks of Gel White and Veegum.
Advantageously, the silicates will be finally divided powders having an average particle size ranging from 0.0001 micron to 50 micron, preferably from 0.01 micron to 10 micron, more preferably from 0.1 to 1.5 micron. Amounts of 20 the silicate may range from 0.1 to 20%, preferably from 0.5 to 10%, optimally from 1 to 5% by weight of the composition.
A second element of the present invention is that of a crosslinked carboxyvinyl polymer other than a long chain
C10-C30 alkyl acrylate or methacrylate containing polymer.
25 Illustrative are acrylic acid/ethyl acrylate copolymers and
the carboxyvinyl polymers sold under the Carbopol
trademark. The latter consists essentially of a colloidally water-soluble polyalkyenyl polyether crosslinked polymer of

WO 02/092051

PCT/EP02/04955

acrylic acid crosslinked with from 0.75% to 2.00% of a crosslinking agent such as a polyallyl sucrose or polyallyl pentaerythritol. Specific commercial examples include
Carbopol® 934, Carbopol® 940, Carbopol® 950, Carbopol® 951, 5 Carbopol® 980, Carbopol® 981 and Carbopol® 1342.
Particularly useful in Carbopol 934, a water-soluble
polymer of acrylic acid crosslinked with about 1% of a polyallyl ether of sucrose having an average of about 5.8 allyl groups for each sucrose molecule. These materials are 10 described in U.S. Patent 2,798,053 (Brown) herein incorporated by reference. Long chain fatty group substituted polymeric ester of acrylic or methacrylic acid •
such as Pemulen with CTFA name of acrylates/C10-30 alkyl
acrylate crosspolymer are outside the scope of this 15 invention. Amounts of the polymer may range from about
0.001 to about 2%, preferably from about 0.005 to about 1%, optimally from about 0.01 to about 0.1% by weight of the composition.
Another important element of the present invention is that 20 of a silicone copolyol sulfosuccinate.
The preferred silicone copolyol sulfosuccinate is of the formula:

WO (12/092051

PCT/EP02/04955


wherein R is an alkylene oxide polymer; M is a cation selected from the group consisting of hydrogen, alkali metal, alkaline earth metal, ammonium and alkanolammonium ions, x and y range in value so as to produce a compound with an equivalent weight between 700 and 1600 grams. R may be further defined as a polymer of ethylene or propylene oxide in the following forms:
(—CH2—CH20)aH;
wherein a and b independently range in value from 1 to 30; and

WO 02/092051

PCT/EP02/04955


wherein a and b may independently range in value from 0 to 5 30.
A related preferred silicone copolyol sulfosuccinate structure according to the present invention is represented by the formula:


X

wherein X is an amine group obtained from alcohol amines, ethoxylates or propoxylates, preferably derived from the group consisting of monoethanolamine, diethanolamine, triethanolamine, monoisopropanolamine or diglycolamine.

WO 02/092051

PCT/EP02/04955

A further related preferred silicone copolyol sulfosuccinate structure according to the present invention is represented by the formula:


10

wherein M' is an alkaline earth metal, for example, calcium, magnesium or barium, rather than an alkali metal.
15 A still further related preferred silicone copolyol
sulfosuccinate structure according to the present invention is represented by the following formula:

WO (12/092051

PCT/EP02/0495!


10
wherein X is an amine group as described above and obtained from sulfite salts containing the amine group.
The silicone copolyol sulf©succinates of the present invention are generally prepared by reacting the ethoxylated
15 polyether side chains of dimethicone copolyol with maleic anhydride to form a monoester and then converting the monoester to sulfosuccinate by sulfonation of the double bond with a metallic sulfite. Metallic sulfite and amine salts may also be used either alone or in combination for
20 sulfonation of the double bond. The resulting
sulfosuccinate is a silicone-based surfactant which exhibits highly improved mildness and foam stabilizing properties.

WO 02/092051

PCT/EP02/04955

Commercially, the silicone copolyol sulfosuccinates are available from the Mclntyre Chemical Company under the trademark of Mackanate DC-30 and DC-3 0A.
Amounts of the silicone copolyol sulfosuccinate for use in 5 compositions of the present invention may range from 0.01 to 40%, preferably from 0.1 to 20%, more preferably from 0.2 to 10%, optimally between 0.3 and 2% by weight.
An optional further component of cosmetic cream compositions 10 according to the present invention is that of an anionic co-surfactant. Illustrative but not limiting examples include the following classes:
(1) Alkyl benzene sulfonates in which the alkyl group
15 contains from 9 to 15 carbon atoms, preferably 11
to 14 carbon atoms in straight chain or branched chain configuration. Especially preferred is a linear alkyl benzene sulfonate containing about 12 carbon atoms in the alkyl chain. 20
(2) Alkyl sulfates obtained by sulfating an alcohol
having 8 to 22 carbon atoms, preferably 12 to 16
carbon atoms. The alkyl sulfates have the formula
R0SO3-M+ where R is the C8-22 alkyl group and M is a
25 mono- and/or divalent cation.
(3) Paraffin sulfonates having 8 to 22 carbon atoms,
preferably 12 to 16 carbon atoms, in the alkyl

WO 02/092051

PCT/EP02/04955
moiety. These surfactants are commercially available as Hostapur SAS from Hoechst Celanese,
(4) Olefin sulfonates having 8 to 22 carbon atoms,
preferably 12 to 16 carbon atoms. Most preferred
is sodium C14-C16 olefin sulfonate, available as Bioterge AS 40®
(5) Alkyl ether sulfates derived from an alcohol
having 8 to 22 carbon atoms, preferably 12 to 16
carbon atoms, ethoxylated with less than 30,
preferably less than 12, moles of ethylene oxide.
Most preferred is sodium lauryl ether sulfate
formed from 2 moles average ethoxylation,
commercially available as Standopol ES-2®.
(6) Alkyl glyceryl ether sulfonates having 8 to 22 carbon atoms, preferably 12 to 16 carbon atoms, in the alkyl moiety.
(7) Fatty acid ester sulfonates of the formula:
1
R CH(S03-M+)CO2R2 where R1 is straight or branched
alkyl from about C8 to C18, preferably C12 to C16,

and R2 is straight or branched alkyl from about C1
to C6, preferably primarily C1, and M+ represents a mono- or divalent cation.
(8) Secondary alcohol sulfates having 6 to 18,
preferably 8 to 16 carbon atoms.

WO 02/092051

PCT/EP02/04955

(9) Fatty acyl isethionates having from 10 to 22
carbon atoms, with sodium cocoyl isethionate being preferred.
5 (10) Dialkyl sulfosuccinates wherein the alkyl groups range from 3 to 20 carbon atoms each.
(11) Alkanoyl sarcosinates corresponding to the formula
RCON(CH3)CH2CH2C02M wherein R is alkyl or alkenyl
10 of about 10 to about 20 carbon atoms and M is a
water-soluble cation such as ammonium, sodium, potassium and trialkanolammonium. Most preferred is sodium lauroyl sarcosinate.
15 Amounts of the anionic co-surfactant if included in the
composition may range from 0.1 to 40%, preferably from 0.5 to 25%, optimally from 5 to 20% by weight of the cosmetic composition.
20 Surfactants other than anionics may also be present to aid in the foaming, detergency and mildness properties. Nonionic and amphoteric actives are the preferred co-surfactants. Suitable nonionic surfactants include C10-C20
fatty alcohol or acid hydrophobes condensed with from 2 to 25 100 moles of ethylene oxide or propylene oxide per mole of
hydrophobe; C2-C10 alkyl phenols condensed with from 2 to 20
moles of alkylene oxides; mono- and di- fatty acid esters of ethylene glycol such as ethylene glycol distearate; fatty
acid monoglycerides; sorbitan mono- and di- C8-C20 fatty
30 acids; and polyoxyethylene sorbitan available as Polysorbate

WO 02/092051

PCT/EP02/04955
80 and Tween 80® as well as combinations of any of the above surfactants.Other useful nonionic surfactants include alkyl 5 plyglycosides, saccharide fatty amides (e.g. methyl
gluconamides) as well as long chain tertiary amine oxides. Examples of the latter category are: dimethyldodecylamine oxide, oleyldi(2-hydroxyethyl)amine oxide, dimethyloctylamine oxide, dimethyldecylamine oxide, 10 dimethyltetradecylamine oxide, di(2-
hydroxyethyl)tetradecylamine oxide, 3-didodecoxy-2-hydroxypropyldi (3 -hydroxypropyl) amine oxide, and dimethylhexadecylamine oxide.
15 Amounts of the nonionic surfactant if included in the
composition may range from 0.1 to 40%, preferably from 0.5 to 15%, optimally from 1 to 5% by weight of the total composition.
20 Amphoteric surfactants such as betaines may also be employed
as co-actives. Suitable betaines may have the general
+ formula RN (R1)2R2 COO wherein R is a hydrophobic moiety
selected from the group consisting of alkyl groups containing from 10 to 22 carbon atoms, preferably from 12 to 25 18 carbon atoms; alkyl aryl and aryl alkyl groups containing 10 to 22 carbon atoms with a benzene ring being treated as equivalent to about 2 carbon atoms, and similar structures
interrupted by amido or ether linkages; each R is an alkyl

group containing from 1 to 3 carbon atoms; and R2 is an
30 alkylene group containing from 1 to about 6 carbon atoms.

WO 02/092051

PCT/EP02/04955


Sulfobetaines such as cocoamidopropyl sultaine are also suitable.
Examples of preferred betaines are dodecyl dimethyl betaine, 5 cetyl dimethyl betaine, dodecyl amidopropyldimethyl betaine, tetradecyldimethyl betaine, tetradecylamidopropyldimethyl betaine, and dodecyldimethylammonium hexanoate. Most preferred is cocoamidopropyl betaine available as
Tegobetaine F® sold by Th. Goldschmidt AG of Germany.
10 Amounts of the betaine if present in the composition may range from 0.05 to 15%, preferably from 0.5 to 10%, optimally from 2 to 8% by weight of the total composition.
Moisturizing ingredients may also be included in 15 compositions of the present invention. Water soluble
moisturizers such as polyhydric alcohol-type humectants are particularly preferred. Typical polyhydric alcohols include glycerol (also known as glycerin), polyalkylene glycols and more preferably alkylene polyols and their derivatives, 20 including propylene glycol, dipropylene glycol,
polypropylene glycol, polyethylene glycol and derivatives thereof, sorbitol, hydroxypropyl sorbitol, hexylene glycol, 1,3-butylene glycol, isoprene glycol, 1,2,6-hexanetriol, ethoxylated glycerol, propoxylated glycerol and mixtures 25 thereof. For best results the humectant is preferably
glycerin. The amount of humectant may range anywhere from 0.5 to 30%, preferably between 1 and 15% by weight of the composition.
30 Preservatives can desirably be incorporated into the
cosmetic compositions of this invention to protect against


WO 02/092051

PCT/EP02/04955

the growth of potentially harmful microorganisms. Suitable traditional preservatives are EDTA salts and alkyl esters of para-hydroxybenzoic acid. Other preservatives which have more recently come into use include hydantoin derivatives, 5 propionate salts, and a variety of quaternary ammonium
compounds. Cosmetic chemists are familiar with appropriate preservatives and routinely choose them to satisfy the preservative challenge test and to provide product stability. Particularly preferred preservatives are
10 iodopropynyl butyl carbamate, phenoxyethanol, methyl paraben, propyl paraben, imidazolidinyl urea, sodium dehydroacetate and benzyl alcohol. The preservatives should be selected having regard for the use of the composition and possible incompatibilities between the preservatives and
15 other ingredients in the composition. Preservatives are preferably employed in amounts ranging from about 0.01% to about 2% by weight of the composition.
Minor adjunct ingredients may be present in the cosmetic 20 compositions. Among them may be the water-soluble vitamins, colorants, fragrances and botanicals. Each of these substances may range from 0.05 to 5%, preferably between 0.1 and 3% by weight.
25 Cationic conditioning agents in monomeric and polymeric type are also useful for purposes of this invention. Examples of the polymeric type include: cationic cellulose derivatives, cationic starches, copolymers of a diallyl quaternary ammonium salt and an acryl amide, quaternized
30 vinylpyrrolidone, vinylimidazole polymers, polyglycol amine condensates, quaternized collagen polypeptide, polyethylene

WO 02/092051 PCT/EP02/04955


10

imine, cationized silicon polymer (e.g. Amodimethicone), cationic silicon polymers provided in a mixture with other components under the trademark Dow Corning 929 (cationized emulsion), copolymers of adipic acid and dimethylaminohydroxypropyl diethylenetriamine, cationic chitin derivatives, cationized guar gum (e.g. Jaguar C-B-S, Jaguar C-17, Jaguar C-16, etc. manufactured by the Celanese Company) , quaternary ammonium salt polymers (e.g. Mirapol A-15, Mirapol AD-1, Mirapol AZ-1 manufactured by the Miranol Divison of the Rhone Poulenc Company) . Most preferred is
polyquaternium-11 available as Luviquat® PQ 11 sold by the
BASF Corporation.

Examples of suitable monomeric cationic conditioning agents 15 are salts of the general structure:


20

wherein R is selected from an alkyl group having from 12 to 25 22 carbon atoms, or aromatic, aryl or alkaryl groups having

from 12 to 22 carbon atoms; R1 , R2 , and R4 are independently
selected from hydrogen, an alkyl group having from 1 to 22 carton atoms, or aromatic, aryl or alkaryl groups having
from 12 to 22 carbon atoms; and X is an anion selected from
30 chloride, bromide, iodide, acetate, phosphate, nitrate,

WO 02/092051

PCT/EP02/04955

sulfate, methyl sulfate, ethyl sulfate, tosylate, lactate, citrate, glycolate, and mixtures thereof. Additionally, the alkyl groups can also contain ether linkages, or hydroxy or amino group substituents (e.g., the alkyl groups can contain 5 polyethylene glycol and polypropylene glycol moieties) . Preferably the anion is phosphate, especially preferred is hydroxy ethyl cetyl dimonium phosphate available as
Luviquat^ Mono CP from the BASF Corporation.
10 Amino silicone quats may similarly be employed. Most
preferred is Silquat AD designated by the CTFA as Silicone Quaternium 8, available from Siltech Inc.
Amounts of each cationic agent may range from 0.05 to 5%, 15 preferably from 0.1 to 3%, optimally from 0.3 to 2.5% by weight.
A cosmetically acceptable carrier is also necessary for compositions of the present invention. Most often the 20 carrier is water. Amounts of water may range from 2% to
98%, preferably from 25 to 85%, optimally from 40 to 70% by weight of the composition.
Emollients may also be incorporated in compositions of the
present invention. Illustrative are C8-C24 fatty acids and
25 fatty alcohols. Representative fatty acids include lauric acid, palmitic acid, stearic acid, hydroxy stearic acid, oleic acid, behenic acid and combinations thereof. Illustrative fatty alcohols include lauryl alcohol, myristyl alcohol, cetearyl alcohol, stearyl alcohol, hydroxy stearyl

• WO 02/092051

PCT/EP02/04955
alcohol, oleyl alcohol and behenyl alcohol. Amounts of the fatty acids and fatty alcohols respectively may range from 0.1 to 2 0%, preferably from 0.5 to 10%, optimally from 1 to 5% by weight of the composition.
5 Compositions of this invention will have a viscosity ranging from 20,000 to 500,000 centipoise, preferably from 40,000 to 100,000, optimally from 60,000 to 75,000 centipoise. Viscosity is measured on a Brookfield RVT Viscometer utilizing Spindle TC, rotated at 5 rpm at 22°C.
10 Compositions of the present invention will preferably lie within a pH range from 3.5 to 6.8, preferably from 5 to 6.
Some embodiments of the present invention may be formulated with insoluble particles to provide aesthetic appeal. These particles may be inorganic materials such as mica, titanium
15 dioxide, fused silica or combinations. Illustrative is a mica/titanium dioxide particle sold under the Ultra Sparkle brand, available from Flamenco Inc. Particles may also be in the form of finely ground plastics such as polyolefins, polyesters and polyamides. Particularly suitable is
20 polyethylene. Encapsulates may also serve as suspended particles. For instance, a polysaccharide such as agar, gelatin, carageenan, xanthan gum or guar gum may be dispersed as particulates. These substances can encapsulate active materials such as Vitamin C, retinol or alpha hydroxy
25 acids. Particles for this embodiment may have an average particle size ranging from 100 micron to 10,000 micron, preferably from 500 micron to 5,000 micron, optimally from 1,000 micron to 3,000 micron.

WO 02/092051

PCT/EP02/04955

Except in the operating and comparative examples, or where otherwise explicitly indicated, all numbers in this description indicating amounts of material ought to be understood as modified by the word "about". 5
The term "comprising" is meant not to be limiting to any subsequently stated elements but rather to encompass non-specified elements of major or minor functional importance. In other words the listed steps, elements or options need 10 not be exhaustive.
The following examples will more fully illustrate the embodiments of this invention. All parts, percentages and proportions referred to herein and in the appended claims 15 are by weight unless otherwise indicated.
EXAMPLES 1-8
Creamy cosmetic cleanser compositions according to this 2 0 invention are formulated with the components listed under Table I.

TABLE I


WO 02/092051

PCT/EP02/04955

EXAMPLE 9
A series of experiments were conducted to evaluate the physical property effects of silicate, crosslinked 5 carboxyvinyl polymer and dimethicone copolyol
sulfosuccinate. Six formulations were prepared (A-G) . These are listed in the Table below.

Table II


WO 02/092051

PCT/EP02/04955

Sample A is reflective of the present invention. This formula had a satisfactory viscosity with nice skin feel, good lather and good storage stability. Sample B included
Gel White® (silicate) and Carbopol® 980 (crosslinked
5 carboxyvinyl polymer) but omitted the dimethicone copolyol sulfosuccinate. Although Sample B exhibited the desired high viscosity, the feel was rather gritty in a manner unacceptable to most consumers. Sample C combined the Gel

White® with the dimethicone copolyol sulfosuccinate but
L0 removed Carbopol® 980. The result was a product of
borderline viscosity, although having nice skinfeel and good lather. Sample C was not stable and separated within two weeks of oven storage at 50°C. Sample D omitted both Gel White® and Carbopol® 980. The result was an extremely low 15 viscosity product that was not stable separating within three days. Sample E lacked Gel White® but did include
Carbopol® 980 and dimethicone copolyol sulfosuccinate.
Viscosity was found to be too low and the formula unstable
separating within three days of storage at 50°C. Sample F
20 omitted both Gel White® and Carbopol® 980. Long term
stability was inadequate; separation occurred within 4 weeks
at 50°C. Sample G is identical to Sample A except that
Pemulen® replaces Carbopol®. Long term stability of Sample
G was inadequate. Evident from this study is that all three 25 components are necessary for the present invention.

WO 02/092051 PCT/EP02/04955WE CLAIMS
1. A cosmetic cream cleanser composition comprising:
(i) from 0.1 to 20% of a silicate;
5 (ii) from 0.001 to 2% of a crosslinked
carboxyvinyl polymer other than a long chain
C10-C30 alkyl acrylate or methacrylate
containing polymer;
(iii) from 0.01 to 40% of a silicone copolyol
10 sulfosuccinate; and
(iv) a cosmetically acceptable carrier;
wherein the composition has a viscosity ranging from 20,000 to 500,000 cp when measured on a Brookfield RUT Viscometer utilising spindle TC at 5rpm at 22 °C.
15 2. The composition according to claim 1 wherein the silicate is an aluminum magnesium silicate.
3. The composition according to claim 1 or claim 2 wherein the silicone copolyol sulfosuccinate is a dimethicone copolyol sulfosuccinate.
20 4. The composition according to any of the preceding claims wherein the silicate is present in an amount from 1 to 5% by weight of the composition.
5. The cosmetic composition according to any of the
preceding claims wherein the composition has a viscosity 25 ranging from 60,000 to 75,000 cp when measured on a

WO 02/092051

PCT/EP02/04955

Brookfield RUT Viscometer utilising spindle TC at 5rpm at 22°C.
Dated this 6th day of November 2003
HINDUSTAN LEVER LIMITED
(S. Venkatramani)
Senior Patents Manager

Documents

Application Documents

# Name Date
1 1021-mumnp-2003-form 19(13-11-2003).pdf 2003-11-13
1 205410-FORM 27-2010.pdf 2024-03-04
2 205410-FORM 27-2013.pdf 2024-02-29
2 1021-MUMNP-2003-CORRESPONDENCE(RENEWAL PAYMENT LETTER)-(22-03-2011).pdf 2011-03-22
3 1021-mumnp-2003-u.s.patent.pdf 2018-08-08
3 1021-MUMNP-2003-RELEVANT DOCUMENTS [29-09-2023(online)].pdf 2023-09-29
4 1021-MUMNP-2003-RELEVANT DOCUMENTS [20-09-2022(online)].pdf 2022-09-20
4 1021-mumnp-2003-powar attorney.pdf 2018-08-08
5 1021-MUMNP-2003-RELEVANT DOCUMENTS [09-09-2021(online)].pdf 2021-09-09
5 1021-mumnp-2003-pct-isa 416.pdf 2018-08-08
6 1021-mumnp-2003-pct-isa 210.pdf 2018-08-08
7 1021-mumnp-2003-pct-ipea 409.pdf 2018-08-08
7 1021-mumnp-2003-claims.pdf 2018-08-08
8 1021-mumnp-2003-pct document.pdf 2018-08-08
8 1021-MUMNP-2003-CORRESPONDENCE(8-2-2012).pdf 2018-08-08
9 1021-mumnp-2003-correspondence(ipo).pdf 2018-08-08
10 1021-MUMNP-2003-CORRESPONDENCE(RENEWAL PAYMENT LETTER)-(26-3-2012).pdf 2018-08-08
10 1021-mumnp-2003-form 5.pdf 2018-08-08
11 1021-mumnp-2003-correspondence.pdf 2018-08-08
11 1021-mumnp-2003-form 2(title page).pdf 2018-08-08
12 1021-mumnp-2003-form 2(provisional).pdf 2018-08-08
13 1021-mumnp-2003-description(granted).pdf 2018-08-08
13 1021-mumnp-2003-form 2(granted).pdf 2018-08-08
14 1021-mumnp-2003-examiniation report.pdf 2018-08-08
14 1021-mumnp-2003-form 1a.pdf 2018-08-08
15 1021-mumnp-2003-form 1a(superceded).pdf 2018-08-08
16 1021-mumnp-2003-examiniation report.pdf 2018-08-08
16 1021-mumnp-2003-form 1a.pdf 2018-08-08
17 1021-mumnp-2003-form 2(granted).pdf 2018-08-08
17 1021-mumnp-2003-description(granted).pdf 2018-08-08
18 1021-mumnp-2003-form 2(provisional).pdf 2018-08-08
19 1021-mumnp-2003-correspondence.pdf 2018-08-08
19 1021-mumnp-2003-form 2(title page).pdf 2018-08-08
20 1021-MUMNP-2003-CORRESPONDENCE(RENEWAL PAYMENT LETTER)-(26-3-2012).pdf 2018-08-08
20 1021-mumnp-2003-form 5.pdf 2018-08-08
21 1021-mumnp-2003-correspondence(ipo).pdf 2018-08-08
22 1021-MUMNP-2003-CORRESPONDENCE(8-2-2012).pdf 2018-08-08
22 1021-mumnp-2003-pct document.pdf 2018-08-08
23 1021-mumnp-2003-claims.pdf 2018-08-08
23 1021-mumnp-2003-pct-ipea 409.pdf 2018-08-08
24 1021-mumnp-2003-pct-isa 210.pdf 2018-08-08
25 1021-mumnp-2003-pct-isa 416.pdf 2018-08-08
25 1021-MUMNP-2003-RELEVANT DOCUMENTS [09-09-2021(online)].pdf 2021-09-09
26 1021-MUMNP-2003-RELEVANT DOCUMENTS [20-09-2022(online)].pdf 2022-09-20
26 1021-mumnp-2003-powar attorney.pdf 2018-08-08
27 1021-mumnp-2003-u.s.patent.pdf 2018-08-08
27 1021-MUMNP-2003-RELEVANT DOCUMENTS [29-09-2023(online)].pdf 2023-09-29
28 205410-FORM 27-2013.pdf 2024-02-29
28 1021-MUMNP-2003-CORRESPONDENCE(RENEWAL PAYMENT LETTER)-(22-03-2011).pdf 2011-03-22
29 205410-FORM 27-2010.pdf 2024-03-04
29 1021-mumnp-2003-form 19(13-11-2003).pdf 2003-11-13

ERegister / Renewals

3rd: 24 Jul 2007

From 03/05/2004 - To 03/05/2005

4th: 24 Jul 2007

From 03/05/2005 - To 03/05/2006

5th: 24 Jul 2007

From 03/05/2006 - To 03/05/2007

6th: 24 Jul 2007

From 03/05/2007 - To 03/05/2008

7th: 30 Apr 2008

From 03/05/2008 - To 03/05/2009

8th: 27 Apr 2009

From 03/05/2009 - To 03/05/2010

9th: 27 Apr 2010

From 03/05/2010 - To 03/05/2011

10th: 22 Mar 2011

From 03/05/2011 - To 03/05/2012

11th: 26 Mar 2012

From 03/05/2012 - To 03/05/2013

12th: 02 Apr 2013

From 03/05/2013 - To 03/05/2014

13th: 26 Mar 2014

From 03/05/2014 - To 03/05/2015

14th: 31 Mar 2015

From 03/05/2015 - To 03/05/2016

15th: 22 Mar 2016

From 03/05/2016 - To 03/05/2017

16th: 16 Mar 2017

From 03/05/2017 - To 03/05/2018

17th: 16 Mar 2018

From 03/05/2018 - To 03/05/2019

18th: 25 Mar 2019

From 03/05/2019 - To 03/05/2020

19th: 17 Mar 2020

From 03/05/2020 - To 03/05/2021